CCP
EW icon

Clough Capital Partners’s Edwards Lifesciences EW Stock Holding History

Clough Capital Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-114,600
Closed -$3.37M – 198
2016
Q1 		$3.37M Buy
+114,600
New +$3.16M 0.16% 121

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Clough Capital Partners's EW Position: Q2 2016 in Review

Clough Capital Partners sold out of Edwards Lifesciences (EW) in Q2 2016, closing a stake of 114,600 shares — an estimated $3.37M sold.

Clough Capital Partners first reported a position in EW in Q1 2016 and held it in 1 quarter. The position peaked at $3.37M in Q1 2016. 693 funds tracked by Wall St. Rank hold EW as of Q2 2016.

  • Clough Capital Partners reported no remaining Edwards Lifesciences position as of Q2 2016 after selling out during the quarter.
  • Clough Capital Partners sold 114,600 Edwards Lifesciences shares in Q2 2016, an estimated $3.37M.
  • Clough Capital Partners first reported a position in Edwards Lifesciences in Q1 2016 and held it in 1 quarter.
  • Clough Capital Partners's Edwards Lifesciences position peaked at $3.37M in Q1 2016.
  • 693 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2016.

Based on Clough Capital Partners's 13F filing for Q2 2016, filed 15 Aug 2016.